Your browser doesn't support javascript.
loading
Cardioneuroablation for Drug Refractory Vasovagal Syncope After COVID-19 Infection.
Zafeiropoulos, Stefanos; Beccarino, Nicholas J; Stavrakis, Stavros; Zanos, Stavros; Mitra, Raman.
Afiliación
  • Zafeiropoulos S; Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
  • Beccarino NJ; Northwell Health, North Shore University Hospital, Department of Cardiology, Division of Electrophysiology, Manhasset, New York, USA.
  • Stavrakis S; Heart Rhythm Institute, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA.
  • Zanos S; Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
  • Mitra R; Northwell Health, North Shore University Hospital, Department of Cardiology, Division of Electrophysiology, Manhasset, New York, USA.
JACC Case Rep ; 29(13): 102373, 2024 Jul 03.
Article en En | MEDLINE | ID: mdl-38827268
ABSTRACT
Cardioneuroablation is a novel approach to treat patients with recurrent vasovagal syncope (VVS), targeting the ganglionated plexi around the atria and thus reducing the vagal input to the heart. This study reports a case of drug-refractory VVS after COVID-19 infection, successfully managed with cardioneuroablation.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: JACC Case Rep Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: JACC Case Rep Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos